Research interests
Fundamental discovery research into human heart failure[5]
Richard Shannon
As of 2021 · Last known relationship
As of 2021 · Last known relationship
Gave up his research career to develop quality platforms in healthcare
His laboratory was the first to discover beneficial cardiovascular actions of incretins, work that formed the basis for Ventrigen, LLC
Richard P. Shannon matters for linking cardiovascular research with health-system quality and patient-safety leadership. He is Professor of Medicine in Cardiology at Duke University and serves as Senior Vice President and Chief Medical Officer of Duke University Health System, as well as Chief Quality Officer for Duke Health. His M.D. is from the University of Connecticut School of Medicine (1980). His career includes an instructor role in medicine, 17 years at Harvard Medical School, and roles at Drexel, the University of Pennsylvania, Allegheny General Hospital, and the University of Virginia. His investigative interests include myocardial metabolism and heart failure, particularly energetics in disease progression. His laboratory’s incretin research formed the basis for Ventrigen. He later redirected part of his research effort toward developing healthcare quality platforms.
Spent 17 years at Harvard Medical School
Each topic is linked to its supporting source in Sources.
Training includes Leaning into Harm: The Evolving Partnership Between the Duke Quality System and Clinical Departments, M.D., University of Connecticut, School of Medicine, Professor of Medicine, and Senior Vice Chair for Clinical Affairs, Department of Medicine, plus 19 more records.
Explore education and trainingAs of 2020
2000
As of 1980
As of 2021
Fundamental discovery research into human heart failure[5]
Myocardial metabolism and heart failure, particularly the role of energetics in heart failure progression[6]
Using Lean methods to reduce patient infections and improve clinical outcomes[11]